Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1-Reference-Cited by-同舟云学术

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Published:2008-09-02 Issue:9 Volume:118 Page:3132-3142
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Hacein-Bey-Abina Salima,Garrigue Alexandrine,Wang Gary P.,Soulier Jean,Lim Annick,Morillon Estelle,Clappier Emmanuelle,Caccavelli Laure,Delabesse Eric,Beldjord Kheira,Asnafi Vahid,MacIntyre Elizabeth,Dal Cortivo Liliane,Radford Isabelle,Brousse Nicole,Sigaux François,Moshous Despina,Hauer Julia,Borkhardt Arndt,Belohradsky Bernd H.,Wintergerst Uwe,Velez Maria C.,Leiva Lily,Sorensen Ricardo,Wulffraat Nicolas,Blanche Stéphane,Bushman Frederic D.,Fischer Alain,Cavazzana-Calvo Marina

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference55 articles.

1. Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease

2. Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy

3. Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

4. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

5. LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

Cited by 1552 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The longitudinal kinetics of AAV5 vector integration profiles and evaluation of clonal expansion in mice;Molecular Therapy - Methods & Clinical Development;2024-09

2. The Role of the Conditioning Regimen for Autologous and Ex Vivo Genetically Modified Hematopoietic Stem Cell-based Therapies: Recommendations from the ISCT Stem Cell Engineering Committee;Cytotherapy;2024-09

3. Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia;Frontiers in Endocrinology;2024-08-30

4. Adeno-Associated Virus Vectors—a Target of Cellular and Humoral Immunity—are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies;Human Gene Therapy;2024-08-28

5. Targeting multiple hallmarks of mammalian aging with combinations of interventions;Aging;2024-08-18